Inventor · disambiguated record
Charles Z. Ding
Also filed as: DING CHARLES · DING CHARLES Z · DING CHARLES Z Z
79 granted patents·38 pending applications·785 citations·filing 1993–2025
99Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD23MEDSHINE DISCOVERY INC22BRISTOL MYERS SQUIBB CO15ANACOR PHARMACEUTICALS INC7FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD6
Top patents by PatentIndex Score
117 records- 0197US5547966AAryl urea and related compoundsBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Aug 20, 1996·125 cites·5 claims
- 0296US8039450B2Boron-containing small molecules as anti-inflammatory agentsANACOR PHARMACEUTICALS INC·Filed 2009·Granted Oct 18, 2011·63 cites·107 claims
- 0396US6011029AInhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jan 4, 2000·107 cites·7 claims
- 0495US6916813B2(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolaseBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·80 cites·25 claims
- 0593US8461135B2Boron-containing small molecules as anti-inflammatory agentsAKAMA TSUTOMU·Filed 2011·Granted Jun 11, 2013·28 cites·40 claims
- 0693US8343944B2Trisubstituted boron-containing moleculesANACOR PHARMACEUTICALS INC·Filed 2010·Granted Jan 1, 2013·34 cites·59 claims
- 0791US9969719B2Substituted 2-hydrogen-pyrazole derivative serving as anticancer drugCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted May 15, 2018·9 cites·15 claims
- 0891US6875782B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Apr 5, 2005·46 cites·15 claims
- 0991US6458783B1Non-imidazole benzodiazepine inhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 1, 2002·29 cites·4 claims
- 1088US8703742B2Boron-containing small moleculesHERNANDEZ VINCENT S·Filed 2011·Granted Apr 22, 2014·11 cites·25 claims
- 1188US5869478ASulfonamido substituted benzopyran derivativesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Feb 9, 1999·45 cites·6 claims
- 1286US6602883B1Inhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Aug 5, 2003·23 cites·7 claims
- 1385US7238694B2Rifamycin imino derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 3, 2007·6 cites·51 claims
- 1485US6156746A1,2,5-benzothiadiazepine-1,1-dioxides with n-2 imidazolylalkyl substituentsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Dec 5, 2000·36 cites·9 claims
- 1583US11459323B2Monocyclic β-lactam compound for treating bacterial infectionMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 4, 2022·3 cites·20 claims
- 1681US7884099B2Quinolone carboxylic acid-substituted rifamycin derivativesCUMBRE IP VENTURES L P·Filed 2008·Granted Feb 8, 2011·7 cites·6 claims
- 1780US12054482B2TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 6, 2024·1 cites·11 claims
- 1880US11453667B2Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted Sep 27, 2022·2 cites·19 claims
- 1979US11623923B2Uracil compound as c-MET/AXL inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Apr 11, 2023·2 cites·23 claims
- 2079US11358950B2SMAC mimetics used as IAP inhibitors and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jun 14, 2022·2 cites·19 claims
- 2179US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
- 2279US7279485B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 9, 2007·11 cites·11 claims
- 2378US7678791B2Nitroheteroaryl-containing rifamycin derivativesCUMBRE IP VENTURES L P·Filed 2007·Granted Mar 16, 2010·4 cites·7 claims
- 2478US6387926B1Inhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 1998·Granted May 14, 2002·38 cites·9 claims
- 2577US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 2676US11691974B23,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitorsMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 4, 2023·1 cites·7 claims
- 2776US10548883B2Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitorGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2017·Granted Feb 4, 2020·1 cites·19 claims
- 2876US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 2976US10093656B2Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitorNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 9, 2018·2 cites·14 claims
- 3076US7951793B2Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 31, 2011·2 cites·6 claims
- 3176US6455523B1Inhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Sep 24, 2002·17 cites·4 claims
- 3274US10227362B2Anti-pulmonary tuberculosis nitroimidazole derivativeMEDSHINE DISCOVERY INC·Filed 2016·Granted Mar 12, 2019·1 cites·11 claims
- 3374US7247634B2Rifamycin derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 24, 2007·3 cites·53 claims
- 3472US12221432B2Estrogen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Feb 11, 2025·1 cites·20 claims
- 3571US10654868B2Dihydropyrazole azepine compound serving as Akt inhibitorHARBIN ZHENBAO PHARMACEUTICAL CO LTD·Filed 2017·Granted May 19, 2020·1 cites·12 claims
- 3671US7666864B2Bicyclic nitroimidazole-substituted phenyl oxazolidinonesGLOBAL ALLIANCE FOR TB DRUG DE·Filed 2009·Granted Feb 23, 2010·3 cites·15 claims
- 3771US7229996B2Rifamycin derivativesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 12, 2007·1 cites·8 claims
- 3871US7226931B2(R/S) rifamycin derivatives, their preparations and pharmaceutical compositionsCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 5, 2007·1 cites·15 claims
- 3970US6624157B2Thiadioxobenzodiazepine inhibitors of farnesyl protein transferaseBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 23, 2003·4 cites·7 claims
- 4070US5837702A4-arylamino-benzopyran and related compoundsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Nov 17, 1998·25 cites·8 claims
- 4169US10428073B2Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2016·Granted Oct 1, 2019·1 cites·13 claims
- 4267US10035792B2Resorcinol derivative as HSP90 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jul 31, 2018·1 cites·20 claims
- 4366US11008345B2Boron-containing small moleculesANACOR PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·0 cites·1 claims
- 4466US10941150B2Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereofHUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC·Filed 2019·Granted Mar 9, 2021·0 cites·12 claims
- 4563US9751898B2Boron-containing small moleculesANACOR PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·0 cites·8 claims
- 4662US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 4762US11180501B2Crystal form of β-lactamase inhibitor and preparation method thereforQILU PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
- 4862US11008331B2Hepatitis B virus surface antigen inhibitorFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Granted May 18, 2021·1 cites·23 claims
- 4962US2025230156A1Crystal form of allyl-containing methylpyridopyrimidine compoundMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 5062US2025361240A1Pyranopyridine compound, process for preparing the same, pharmaceutical composition and use thereofZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2025·Application pending·0 cites
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles Z. Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →